Myth: Alternative nicotine products don't help people stop smoking: Difference between revisions
Jump to navigation
Jump to search
Line 97: | Line 97: | ||
*Validated smoking reduction (including cessation) was achieved by 26.5% vs 6.0% of participants in the EC and NRT study arms, respectively. Sustained validated abstinence rates at 6 months were 19.1% vs 3.0%. | *Validated smoking reduction (including cessation) was achieved by 26.5% vs 6.0% of participants in the EC and NRT study arms, respectively. Sustained validated abstinence rates at 6 months were 19.1% vs 3.0%. | ||
*[https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.15628 PDF Version] | *[https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.15628 PDF Version] | ||
===2021: [https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-021-00475-7 Electronic cigarettes in standard smoking cessation treatment by tobacco counselors in Flanders: E-cigarette users show similar if not higher quit rates as those using commonly recommended smoking cessation aids]=== | ===2021: [https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-021-00475-7 Electronic cigarettes in standard smoking cessation treatment by tobacco counselors in Flanders: E-cigarette users show similar if not higher quit rates as those using commonly recommended smoking cessation aids]=== | ||
*One third of the total sample was biochemically verified smoking abstinent 7 months after quit date, with e-cigarette users (40%) having significantly higher chances to be smoking abstinent than NRT users (23%). | *One third of the total sample was biochemically verified smoking abstinent 7 months after quit date, with e-cigarette users (40%) having significantly higher chances to be smoking abstinent than NRT users (23%). | ||
*[https://harmreductionjournal.biomedcentral.com/track/pdf/10.1186/s12954-021-00475-7.pdf PDF Version] | *[https://harmreductionjournal.biomedcentral.com/track/pdf/10.1186/s12954-021-00475-7.pdf PDF Version] | ||
===2021: [https://pubmed.ncbi.nlm.nih.gov/33798919/ A systematic review of randomized controlled trials and network meta-analysis of e-cigarettes for smoking cessation]=== | ===2021: [https://pubmed.ncbi.nlm.nih.gov/33798919/ A systematic review of randomized controlled trials and network meta-analysis of e-cigarettes for smoking cessation]=== | ||
*Smokers assigned to use nicotine e-cigarettes were more likely to remain abstinent from smoking than those assigned to use licensed NRT, and both were more effective than usual care or placebo conditions. | *Smokers assigned to use nicotine e-cigarettes were more likely to remain abstinent from smoking than those assigned to use licensed NRT, and both were more effective than usual care or placebo conditions. | ||
===2020: [https://pubmed.ncbi.nlm.nih.gov/32770246/ QuitNic: A pilot randomised controlled trial comparing nicotine vaping products with nicotine replacement therapy for smoking cessation following residential detoxification]=== | ===2020: [https://pubmed.ncbi.nlm.nih.gov/32770246/ QuitNic: A pilot randomised controlled trial comparing nicotine vaping products with nicotine replacement therapy for smoking cessation following residential detoxification]=== | ||
Line 114: | Line 109: | ||
*Retention was 63% at 6-weeks and 50% at 12-weeks. At 12-weeks, 68% of the NRT group reported using combination NRT while 96% of the NVP group used the device. Acceptability ratings for the products were high in both groups. At 12-weeks, 14% of the NVP group and 18% of the NRT group reported not smoking at all in the last 7 days. Mean CPD (Cigarettes Per Day) among continued smokers decreased significantly between baseline to 12-weeks in both groups; from 19.91 to 4.72 for the NVP group (p<0.001) and from 20.88 to 5.52 in the NRT group (p<0.001). Cravings and withdrawal symptoms significantly decreased for both groups. | *Retention was 63% at 6-weeks and 50% at 12-weeks. At 12-weeks, 68% of the NRT group reported using combination NRT while 96% of the NVP group used the device. Acceptability ratings for the products were high in both groups. At 12-weeks, 14% of the NVP group and 18% of the NRT group reported not smoking at all in the last 7 days. Mean CPD (Cigarettes Per Day) among continued smokers decreased significantly between baseline to 12-weeks in both groups; from 19.91 to 4.72 for the NVP group (p<0.001) and from 20.88 to 5.52 in the NRT group (p<0.001). Cravings and withdrawal symptoms significantly decreased for both groups. | ||
*[https://sci-hub.se/10.1093/ntr/ntaa143 PDF Version] | *[https://sci-hub.se/10.1093/ntr/ntaa143 PDF Version] | ||
===2020: [https://academic.oup.com/ntr/article/23/4/625/5906696?login=true Effectiveness of Electronic Cigarettes in Smoking Cessation: a Systematic Review and Meta-Analysis]=== | ===2020: [https://academic.oup.com/ntr/article/23/4/625/5906696?login=true Effectiveness of Electronic Cigarettes in Smoking Cessation: a Systematic Review and Meta-Analysis]=== | ||
*Our results suggest that nicotine-ECs may be more effective in smoking cessation when compared to placebo ECs or NRT. | *Our results suggest that nicotine-ECs may be more effective in smoking cessation when compared to placebo ECs or NRT. | ||
*[https://sci-hub.st/10.1093/ntr/ntaa181 PDF Version] | *[https://sci-hub.st/10.1093/ntr/ntaa181 PDF Version] | ||
===2019: [https://www.journalslibrary.nihr.ac.uk/hta/hta23430#/abstract E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT]=== | ===2019: [https://www.journalslibrary.nihr.ac.uk/hta/hta23430#/abstract E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT]=== | ||
Line 130: | Line 121: | ||
*A detailed economic analysis confirmed that, because e-cigarettes incur lower NHS costs than NRT and generate a higher quit rate, e-cigarette use is more cost-effective. | *A detailed economic analysis confirmed that, because e-cigarettes incur lower NHS costs than NRT and generate a higher quit rate, e-cigarette use is more cost-effective. | ||
*[https://njl-admin.nihr.ac.uk/document/download/2030301 PDF Version] | *[https://njl-admin.nihr.ac.uk/document/download/2030301 PDF Version] | ||
<br> | <br> | ||